Mepivacaine Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00961 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 52 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | gastroduodenitis | KG + DL |
| 2 | peptic ulcer disease | KG + DL |
| 3 | gout | KG + DL |
| 4 | bronchitis | KG + DL |
| 5 | rhinitis | KG + DL |
| 6 | infectious otitis media | KG + DL |
| 7 | hypertensive disorder | KG + DL |
| 8 | malignant hypertensive renal disease | KG + DL |
| 9 | malignant renovascular hypertension | KG + DL |
| 10 | pulmonary hypertension with unclear multifactorial mechanism | KG + DL |
| 11 | pulmonary hypertension owing to lung disease and/or hypoxia | KG + DL |
| 12 | middle ear cholesterol granuloma | KG + DL |
| 13 | gastroenteritis | KG + DL |
| 14 | ankylosing spondylitis | KG + DL |
| 15 | chronic pulmonary heart disease | KG + DL |
| 16 | seborrheic dermatitis | KG + DL |
| 17 | otosalpingitis | KG + DL |
| 18 | osteoarthritis susceptibility | KG + DL |
| 19 | allergic otitis media | KG + DL |
| 20 | middle ear disease | KG + DL |
| 21 | rheumatoid vasculitis | KG + DL |
| 22 | chronic otitis media | KG + DL |
| 23 | Braddock syndrome | KG + DL |
| 24 | non-suppurative otitis media | KG + DL |
| 25 | cauda equina syndrome | KG + DL |
| 26 | dermatitis | KG + DL |
| 27 | suppurative otitis media | KG + DL |
| 28 | inflammatory spondylopathy | KG + DL |
| 29 | Kummell disease | KG + DL |
| 30 | hypermobility of coccyx | KG + DL |
| 31 | migraine with brainstem aura | KG + DL |
| 32 | dyspepsia | KG + DL |
| 33 | migraine disorder | KG + DL |
| 34 | vertebral disease | KG + DL |
| 35 | polyarticular juvenile rheumatoid arthritis | KG + DL |
| 36 | exostosis | KG + DL |
| 37 | acrodermatitis chronica atrophicans | KG + DL |
| 38 | gastrointestinal allergy | KG + DL |
| 39 | Smouldering systemic mastocytosis | KG + DL |
| 40 | congestive heart failure | KG + DL |
| 41 | neonatal dermatomyositis | KG + DL |
| 42 | sclerosing cholangitis | KG + DL |
| 43 | acute pulmonary heart disease | KG + DL |
| 44 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 45 | rheumatoid arthritis | KG + DL |
| 46 | obsolete vascular headache | KG + DL |
| 47 | hydroa vacciniforme, familial | KG + DL |
| 48 | kyphoscoliotic heart disease | KG + DL |
| 49 | tenosynovitis | KG + DL |
| 50 | irritable bowel syndrome | KG + DL |
(Showing top 50 of 52 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.